⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BIIB

Biogen Inc.

Healthcare · Drug Manufacturers - General

210.73USD

-1.7700 (-0.83%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ1 FY26Q4 FY25*Q3 FY25Q2 FY25Q1 FY25Q4 FY24*Q3 FY24Q2 FY24
Revenue2,4782,2792,5352,6462,4312,4552,4662,465
Cost of Revenue661496674605629584639546
Gross Profit1,8171,7841,8602,0411,8021,8711,8271,919
Operating Income————————
Net Income320-49467635241267389584
EPS (Diluted)$2.15$-0.35$3.17$4.33$1.64$1.83$2.66$4.00

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)